Exclusion Criteria

Exclusion Criteria refer to predefined clinical trial conditions or patient characteristics that prevent participation in a study, protecting participant safety and ensuring data interpretability. These criteria may include comorbidities, concomitant medications, laboratory abnormalities, prior therapies, or demographic restrictions that increase risk or confound efficacy assessments.

The biopharmaceutical industry designs exclusion criteria to balance safety, scientific rigour, and recruitment feasibility. Overly restrictive criteria may slow enrolment and reduce generalisability, while overly broad criteria may increase variability and safety risks. Regulatory agencies assess whether trial populations appropriately reflect intended use, with increasing emphasis on diversity and broader eligibility where possible. Exclusion criteria must be clearly documented in protocols and informed consent materials, with consistent application across trial sites. As decentralised trials and real-world evidence integration expand, eligibility criteria strategies continue evolving to maintain scientific validity while improving representativeness and access.